|

BMS-986523 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Bristol-Myers Squibb1

Indications

  • Pancreatic Ductal Adenocarcinoma (PDAC)1
  • Non-small Cell Lung Cancer (NSCLC)1
  • Colorectal Cancer (CRC)1
  • Advanced Solid Malignancies1
  • Lung Cancer1

Baltimore, Maryland1 trial

A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

Local Institution - 0009

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.